Tag: https://www.bio.org/events/bio-international-convention
BIO’s Interim President and CEO, Rachel King, talks about her goals for BIO. source
BIO Chair Paul Hastings, CEO of Nkarta Therapeutics, advices biotech leaders to spend time meeting with freshmen Members of Congress, as well as those who have been in office for a while, to help them understand the health care ecosystem and how the industry works. “Being here and being present and spending that time is […]
Emma Andelson of SickCells says she’s looking forward to networking, making new connections and learning at #BIOPatientSummit22. (October 27, 2022) source
Holly Bode of American Kidney Fund talks about the value of connecting with patient advocacy groups in person once again at … source
Carl Schmid of @HIVHep says he made important connections at #BIOPatient Summit22 and plans to work with these people in … source
Patient Advocates do more than raise money—they are active participants in the drug development process. While the ALS Ice Bucket Challenge garnered global attention, lesser-known patient advocates also flex their expertise to drive new treatments and cures. In this episode, we talk with two moms, one who is a patient herself, about their work as […]
At BIO, members drive our advocacy efforts. Across a range of important issues, BIO members are leading efforts to improve … source
U.S.-Taiwan biotech partnership and innovation have been on full display all week at the Taiwan Expo USA in Washington, DC. source
John Murphy, Chief Policy Officer at BIO, delivers his closing comments at BIO’s webinar – Understanding the Prescription Drug … source